| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $351K | — | — |
| R&D Expense | $12.6M | -2.5% | -23.4% |
| SG&A Expense | $9.5M | -7.6% | -25.4% |
| Operating Income | -$22.5M | +9.7% | +22.9% |
| Income Tax | $0 | — | — |
| Net Income | $8.2M | +141.3% | -90.8% |
| EPS (Basic) | $0.94 | +141.4% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.6M | +5.0% | -28.7% |
| Accounts Receivable | $351K | — | — |
| Current Assets | $51.5M | +5.8% | -29.3% |
| Total Assets | $143.5M | -0.2% | -19.7% |
| Current Liabilities | $22.4M | -27.5% | -65.4% |
| Total Liabilities | $99.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $15.8M | — | — |
| Capital Expenditures | $223K | — | — |
| Investing Cash Flow | -$223K | — | — |
| Financing Cash Flow | $1.2M | — | — |
| Free Cash Flow | $15.6M | — | — |
| +62.1% |
| EPS (Diluted) | $0.94 | +141.4% | +62.1% |
| -10.0% |
| -35.6% |
| Stockholders' Equity | $43.7M | +32.6% | +82.7% |